iSpecimen Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- iSpecimen Inc. (Nasdaq: ISPC) operates an online marketplace that connects life science researchers worldwide with healthcare providers offering human biospecimens, including biofluids such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissues comprising fresh, fixed, cryopreserved tissue, formalin-fixed paraffin-embedded blocks, slides, and curls; and hematopoietic stem and immune cells from bone marrow, cord blood, whole blood, or sub-components like peripheral blood mononuclear cells and other isolated cell types. The proprietary iSpecimen Marketplace platform facilitates search, workflow, data management, compliance, and reporting functions, while the company handles marketing, sales, contracting, and quality control services such as centrifugation, custom aliquoting, specimen testing including PBMC isolation and sequencing, slide preparation, and pathology assessments. Founded in 2009 by pathologists and headquartered in Lexington, Massachusetts, with additional facilities in Woburn, Massachusetts, iSpecimen serves researchers in industry, academia, and government across the Americas, Europe, Middle East, Africa, and Asia Pacific, primarily generating revenue from the Americas. In August 2025, iSpecimen closed a $1.75 million private placement priced at-the-market under Nasdaq rules, issuing 1,559,828 shares of common stock and pre-funded warrants to accredited investors, with $500,000 allocated to marketing and advertising services through IR Agency LLC and the balance for working capital and general corporate purposes; WestPark Capital acted as exclusive placement agent. Earlier in July 2025, the company priced a $4 million underwritten public offering at $0.70 per share, including 5.7 million shares, with proceeds designated for $1.5 million in marketing via IR Agency LLC, $1 million milestone payment to Sales Stack Solutions Corp., and general corporate needs. In September 2025, iSpecimen announced plans to establish a corporate treasury reserve of up to $200 million centered on the Solana blockchain ecosystem through collaborations with WestPark Capital and BlockArrow, marking a strategic shift toward decentralized infrastructure and digital assets to enhance technological leadership in life sciences. These funding initiatives and treasury strategy reflect ongoing efforts to fuel marketing expansion, operational milestones, and innovative financial positioning amid revenue growth with a 6-year CAGR of 59%.
Company News
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
iSpecimen Announces 1-for-40 Reverse Stock Split
Why iSpecimen Shares Are Surging On Friday?
Analyzing Agilon Health (NYSE:AGL) & iSpecimen (NASDAQ:ISPC)
iSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours Session
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
Critical Survey: iSpecimen (NASDAQ:ISPC) vs. Progyny (NASDAQ:PGNY)
Head to Head Survey: iSpecimen (NASDAQ:ISPC) & XWELL (NASDAQ:XWEL)
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
iSpecimen (ISPC) Stock Rockets 43% After Hours — Here's Why It's Trending
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete